Pay in 4 interest-free payments of $6.62 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Documentation of the treatment interruption and restart plan in medical records ensures continuity of care and appropriate monitoring throughout the re-titration period
For women using hormonal contraception, discussing the bleeding pattern with a GP or sexual health specialist may lead to adjustments in contraceptive method or formulation
(8.2) Females and Males of Reproductive Potential: For patients receiving WEGOVY for CV risk reduction or weight reduction, or for MASH where the potential risk outweighs the potential benefit, discontinue WEGOVY at least 2 months before a planned pregnancy because of the long half-life of semaglutide
TB-500 (Full Length) Studied as a complete peptide sequence, allowing researchers to investigate the broader range of biological activities associated with the entire molecule
